These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22310475)

  • 1. A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children.
    Olza J; Gil-Campos M; Leis R; Rupérez AI; Tojo R; Cañete R; Gil A; Aguilera CM
    Int J Obes (Lond); 2012 Dec; 36(12):1558-63. PubMed ID: 22310475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
    Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
    Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
    Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
    Li X; Lindquist S; Chen R; Myrnäs T; Angsten G; Olsson T; Hernell O
    Int J Obes (Lond); 2007 May; 31(5):820-8. PubMed ID: 17060929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
    Quteineh L; Vandenberghe F; Saigi Morgui N; Delacrétaz A; Choong E; Gholam-Rezaee M; Magistretti P; Bondolfi G; Von Gunten A; Preisig M; Castelao E; Vollenweider P; Waeber G; Bochud M; Kutalik Z; Conus P; Eap CB
    Pharmacogenet Genomics; 2015 May; 25(5):246-58. PubMed ID: 25751397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in urban Japanese cohort.
    Miyamoto Y; Morisaki H; Yamanaka I; Kokubo Y; Masuzaki H; Okayama A; Tomoike H; Nakao K; Okamura T; Yoshimasa Y; Morisaki T
    Diabetes Res Clin Pract; 2009 Aug; 85(2):132-8. PubMed ID: 19535162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
    Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.
    Makkonen J; Westerbacka J; Kolak M; Sutinen J; Cornér A; Hamsten A; Fisher RM; Yki-Järvinen H
    Int J Obes (Lond); 2007 Oct; 31(10):1617-25. PubMed ID: 17452990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between a 11β-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a South Indian population.
    Gandhi K; Adhikari P; Basu A; Achappa B
    Metab Syndr Relat Disord; 2013 Dec; 11(6):397-402. PubMed ID: 23869418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women.
    Feldman K; Szappanos A; Butz H; Grolmusz V; Majnik J; Likó I; Kriszt B; Lakatos P; Tóth M; Rácz K; Patócs A
    Steroids; 2012 Nov; 77(13):1345-51. PubMed ID: 22986073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
    Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of common genetic variation in 11β-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression.
    Dekker MJ; Tiemeier H; Luijendijk HJ; Kuningas M; Hofman A; de Jong FH; Stewart PM; Koper JW; Lamberts SW
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E233-7. PubMed ID: 22112815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity.
    Lutz SZ; Peter A; Machicao F; Lamprinou A; Machann J; Schick F; Königsrainer I; Königsrainer A; Fritsche A; Staiger H; Häring HU; Stefan N; Kantartzis K
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4743-4751. PubMed ID: 27715400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common polymorphisms in six genes of the methyl group metabolism pathway and obesity in European adolescents.
    Bokor S; Meirhaeghe A; Ruiz JR; Zaccaria M; Widhalm K; Gonzalez-Gross M; Amouyel P; Moreno LA; Molnàr D; Dallongeville J;
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e336-44. PubMed ID: 20883119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
    Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
    Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of variants in the NPY gene on obesity and metabolic syndrome features in Spanish children.
    Olza J; Gil-Campos M; Leis R; Rupérez AI; Tojo R; Cañete R; Gil A; Aguilera CM
    Peptides; 2013 Jul; 45():22-7. PubMed ID: 23624317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK; Nielsen MP; Richelsen B; Bruun JM; Flyvbjerg A; Pedersen SB
    Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.